DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21 juil. 2016 08h30 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
18 mars 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
04 août 2015 15h20 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- August 4, 2015: Provista Diagnostics, Inc., a privately held molecular diagnostics company headquartered in New York, today announced the closing of $6.0...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
11 mars 2015 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
17 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
03 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...
DiamiR Announces Corporate Presentation at Life Sciences Summit 2014
22 oct. 2014 08h02 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - October 22, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Grant From The Michael J. Fox Foundation for Parkinson's Research to Advance Assessment of Brain-Enriched microRNA Biomarkers in Plasma
14 juil. 2014 11h00 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 14, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
DiamiR Announces Oral Presentation at the 2014 Alzheimer's Association International Conference
10 juil. 2014 08h02 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 10, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess the Presence of Breast Cancer
19 mai 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, May 19, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...